Retraction Note: Blockage of Mir-92A-3P With Locked Nucleic Acid Induces Apoptosis and Prevents Cell Proliferation in Human Acute Megakaryoblastic Leukemia (Cancer Gene Therapy, (2016), 23, 1, (29-35), 10.1038/Cgt.2015.63)

Retraction Note: Blockage of Mir-92A-3P With Locked Nucleic Acid Induces Apoptosis and Prevents Cell Proliferation in Human Acute Megakaryoblastic Leukemia (Cancer Gene Therapy, (2016), 23, 1, (29-35), 10.1038/Cgt.2015.63) Publisher Pubmed

Sharifi M¹ ; Salehi R¹

Show Affiliations

1. Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Cancer Gene Therapy Published:2020

Abstract

2. Correction To: Oncolytic Newcastle Disease Virus Delivered by Mesenchymal Stem Cells-Engineered System Enhances the Therapeutic Effects Altering Tumor Microenvironment (Virology Journal, (2020), 17, 1, (64), 10.1186/S12985-020-01326-W), Virology Journal (2020)

3. Author Correction: Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017 (Nature Medicine, (2020), 26, 5, (750-759), 10.1038/S41591-020-0807-6), Nature Medicine (2020)

4. Locked Nucleic Acid Anti-Mir-21 Inhibits Cell Growth and Invasive Behaviors of a Colorectal Adenocarcinoma Cell Line: Lna-Anti-Mir As a Novel Approach, Cancer Gene Therapy (2016)

5. Exosomal Mirnas As Novel Cancer Biomarkers: Challenges and Opportunities, Journal of Cellular Physiology (2018)

6. Inhibition of Microrna-21 Via Locked Nucleic Acid-Anti-Mir Suppressed Metastatic Features of Colorectal Cancer Cells Through Modulation of Programmed Cell Death 4, Tumor Biology (2017)

7. Blockage of Mir-92A-3P With Locked Nucleic Acid Induces Apoptosis and Prevents Cell Proliferation in Human Acute Megakaryoblastic Leukemia, Cancer Gene Therapy (2016)

Experts (# of related papers)

View all Related Experts

Mohammadreza Sharifi (4)

Rasoul Salehi (3)

Style	Citing Format
MLA	Sharifi M, Salehi R. "Retraction Note: Blockage of Mir-92A-3P With Locked Nucleic Acid Induces Apoptosis and Prevents Cell Proliferation in Human Acute Megakaryoblastic Leukemia (Cancer Gene Therapy, (2016), 23, 1, (29-35), 10.1038/Cgt.2015.63)." Cancer Gene Therapy, vol. 27, no. 1-2, 2020, pp. 113-.
APA	Sharifi M, Salehi R (2020). Retraction Note: Blockage of Mir-92A-3P With Locked Nucleic Acid Induces Apoptosis and Prevents Cell Proliferation in Human Acute Megakaryoblastic Leukemia (Cancer Gene Therapy, (2016), 23, 1, (29-35), 10.1038/Cgt.2015.63). Cancer Gene Therapy, 27(1-2), 113-.
Chicago	Sharifi M, Salehi R. "Retraction Note: Blockage of Mir-92A-3P With Locked Nucleic Acid Induces Apoptosis and Prevents Cell Proliferation in Human Acute Megakaryoblastic Leukemia (Cancer Gene Therapy, (2016), 23, 1, (29-35), 10.1038/Cgt.2015.63)." Cancer Gene Therapy 27, no. 1-2 (2020): 113-.
Harvard	Sharifi M, Salehi R (2020) 'Retraction Note: Blockage of Mir-92A-3P With Locked Nucleic Acid Induces Apoptosis and Prevents Cell Proliferation in Human Acute Megakaryoblastic Leukemia (Cancer Gene Therapy, (2016), 23, 1, (29-35), 10.1038/Cgt.2015.63)', Cancer Gene Therapy, 27(1-2), pp. 113-.
Vancouver	Sharifi M, Salehi R. Retraction Note: Blockage of Mir-92A-3P With Locked Nucleic Acid Induces Apoptosis and Prevents Cell Proliferation in Human Acute Megakaryoblastic Leukemia (Cancer Gene Therapy, (2016), 23, 1, (29-35), 10.1038/Cgt.2015.63). Cancer Gene Therapy. 2020;27(1-2):113-.
BibTex	@article{ author = {Sharifi M and Salehi R}, title = {Retraction Note: Blockage of Mir-92A-3P With Locked Nucleic Acid Induces Apoptosis and Prevents Cell Proliferation in Human Acute Megakaryoblastic Leukemia (Cancer Gene Therapy, (2016), 23, 1, (29-35), 10.1038/Cgt.2015.63)}, journal = {Cancer Gene Therapy}, volume = {27}, number = {1-2}, pages = {113-}, year = {2020} }
RIS	TY - JOUR AU - Sharifi M AU - Salehi R TI - Retraction Note: Blockage of Mir-92A-3P With Locked Nucleic Acid Induces Apoptosis and Prevents Cell Proliferation in Human Acute Megakaryoblastic Leukemia (Cancer Gene Therapy, (2016), 23, 1, (29-35), 10.1038/Cgt.2015.63) JO - Cancer Gene Therapy VL - 27 IS - 1-2 SP - 113 EP - PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract